-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Kiniksa Pharmaceuticals International, plc quarterly/annual Revenues history and growth rate from 2022 to Q3 2025.
- Kiniksa Pharmaceuticals International, plc Revenues for the quarter ending September 30, 2025 was $181M, a 61.2% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc annual Revenues for 2024 was $423M, a 56.6% increase from 2023.
- Kiniksa Pharmaceuticals International, plc annual Revenues for 2023 was $270M, a 22.7% increase from 2022.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)